aycan introduces new neuro/oncology workstation

Rochester, N.Y., March 11, 2014--aycan, a recognized worldwide leader in medical imaging, expands its portfolio of specialty imaging workstations with the introduction of aycan Neuro/Oncology workstation. Designed for neuro-oncology applications, the new workstation is powered by aycan workstation OsiriX PRO, and FDA 510(k) cleared plug-ins from partner company Imaging Biometrics, LLC.

aycan’s specialty workstations for Mammography, Oncology, Vascular Surgery, and now Neuro/Oncology provide all the tools for general diagnostic reading and advanced post-processing, plus certified plug-ins beneficial to those specific fields of study. 

“aycan is dedicated to providing high value, low cost plug-ins to our Mac-based post-processing workstation, OsiriX PRO, designed to help improve workflow and productivity in various medical disciplines while reducing costs,” said Frank Burkhardt, aycan Director, North & Latin American Operations. “We chose plug-ins for our Neuro/Oncology workstation from our partner company, Imaging Biometrics, given their extensive software development experience, client-centric focus, and similar quality management approach, which follows ISO standards.”

By leveraging the computational power of IB products, aycan‘s new Neuro/Oncology Workstation enables physicians to make accurate treatment considerations by providing them with proven and exclusive imaging information that has been specifically designed for monitoring therapeutic response in patients with brain cancer and other neurological diseases. “Our plug-ins dovetail seamlessly within the OsiriX PRO workstation and the bundling of our combined solutions offers the neuro-oncological community exciting and rapid access to highly sophisticated technology“, said Michael Schmainda, President and CEO of Imaging Biometrics.

All OsiriX PRO workstations offer excellent image-loading times and intuitive-user interfaces. Increasing their capability is companion product aycan mobile, the FDA-cleared iPad App for Teleradiology, which is designed for easy, fast, and secure viewing and transfer of DICOM images with an iPad. OsiriX PRO is a 64-bit fast, Mac-based, vendor-neutral, highly functional advanced image-processing tool and DICOM PACS workstation for conventional, multi-slice and other image reading. Based on the open source project OsiriX, aycan’s version is turnkey with FDA 510(k) clearance, CE Marking, and full-integration service and customer support.

ABOUT aycan

With a focus on vendor-neutral integration and service, aycan is a worldwide provider of solutions for archiving, viewing, and printing medical images and information that improve workflow efficiency and drive down costs. Leveraging this experience and DICOM expertise, aycan also offers an archive solution built on the companion DICONDE standard for non-destructive testing (NDT) images and information. aycan works with other industry innovators such as Apple, Xerox, MedQ, and EIZO whose quality products are part of their solutions. aycan supports customers worldwide with European headquarters in Wuerzburg, Germany, and U.S. headquarters in Rochester, New York. The company is privately held.

Learn more at www.aycan.com

ABOUT Imaging Biometrics, LLC

Imaging Biometrics develops rapid and robust image processing and advanced visualization tools for the healthcare industry, making them available through application programming interfaces (APIs) and ready to use plug-ins. Through close collaboration with top researchers in the medical imaging field, proprietary and sophisticated advancements are translated into easy and intuitive analytical software solutions for clinicians and researchers.

For more information, visit www.imagingbiometrics.com or call 262-439-8252.

Around the web

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.